Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
Services professionnels
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Bio-based epoxy resin patents are accelerating: lignin, plant oils, HMF, and dynamic covalent bonds are reshaping the $10B+ epoxy market. Full 2026 landscape analysis.
Article | Rapport How whole-body control (WBC) enables dynamic locomotion in humanoid robots — covering inverse dynamics, MPC integration, RL policies, and full-body coordination.
Article | Rapport How whole-body control (WBC) enables dynamic locomotion in humanoid robots — covering inverse dynamics, MPC integration, RL augmentation, and patent trends.
Article | Rapport Patent-based analysis of high-temperature heat pump innovation in 2026: working fluids, compression cycles, digital monitoring, and key assignees driving HTHP decarbonisation.
Article | Rapport How radioligand, bispecific antibody, and CAR-T approaches targeting fibroblast activation protein (FAP) are remodeling the solid tumor microenvironment.
Article | Rapport What causes white spot degradation in perovskite solar panels? Explore ionic defects, UV damage, phase transitions, and the latest prevention strategies from 50+ patents.
Article | Rapport A 2026 patent landscape of AAM propulsion: hydrogen fuel cells, hybrid-electric VTOL, power management, and fleet software. Key signals from 80+ filings.
Article | Rapport What causes white spot degradation in perovskite solar panels? Explore ionic defects, UV damage, phase transitions, and the latest patent-backed prevention strategies.
Article | Rapport Complement inhibition and SGLT2 approaches are reshaping IgAN and FSGS treatment. Explore the patent landscape, key targets, and emerging combination strategies.
Article | Rapport A 2026 patent landscape analysis of space solar power: orbital collection, wireless energy transmission, lunar infrastructure, and AI control systems across 14 key filings.
Article | Rapport Complement inhibition and SGLT2 approaches are reshaping IgAN and FSGS treatment. Explore the patent landscape, key targets, and emerging combination strategies.
Article | Rapport What is V2G technology and what engineering barriers block mass deployment? Patent evidence reveals utilisation rates below 30% and 25-minute mobile dispatch delays.
Article | Rapport AUV patent landscape 2026: deep reinforcement learning, swarm coordination, and cross-domain systems are reshaping underwater robotics. See who's filing and where.
Article | Rapport How NVIDIA's NVLink-C2C die-to-die interconnect eliminates PCIe latency penalties in multi-chip GPU modules like Grace Hopper — patent analysis and benchmarks.
Article | Rapport ARID1A is mutated in up to 50% of ovarian clear-cell carcinomas. Discover how SMARCA4, SMARCA2, PROTACs, and EZH2 inhibitors are reshaping the SWI/SNF cancer therapy landscape.